
### [MONDO:0011096](http://purl.obolibrary.org/obo/MONDO_0011096)
**Label:** autosomal agammaglobulinemia

**Subclasses:** [MONDO:0013287](http://purl.obolibrary.org/obo/MONDO_0013287) (agammaglobulinemia 2, autosomal recessive), [MONDO:0013288](http://purl.obolibrary.org/obo/MONDO_0013288) (agammaglobulinemia 3, autosomal recessive), [MONDO:0013289](http://purl.obolibrary.org/obo/MONDO_0013289) (agammaglobulinemia 4, autosomal recessive), [MONDO:0014840](http://purl.obolibrary.org/obo/MONDO_0014840) (agammaglobulinemia 8, autosomal dominant; AGM8), [MONDO:0013290](http://purl.obolibrary.org/obo/MONDO_0013290) (agammaglobulinemia 5, autosomal dominant), [MONDO:0014083](http://purl.obolibrary.org/obo/MONDO_0014083) (agammaglobulinemia 7, autosomal recessive), [MONDO:0012987](http://purl.obolibrary.org/obo/MONDO_0012987) (agammaglobulinemia 6, autosomal recessive), 

**Mapped go classes:** [GO:0005070](http://purl.obolibrary.org/obo/GO_0005070) (SH3/SH2 adaptor activity), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0046854](http://purl.obolibrary.org/obo/GO_0046854) (phosphatidylinositol phosphorylation), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0046935](http://purl.obolibrary.org/obo/GO_0046935) (1-phosphatidylinositol-3-kinase regulator activity), [GO:0043425](http://purl.obolibrary.org/obo/GO_0043425) (bHLH transcription factor binding), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0005942](http://purl.obolibrary.org/obo/GO_0005942) (phosphatidylinositol 3-kinase complex), [GO:0006910](http://purl.obolibrary.org/obo/GO_0006910) (phagocytosis, recognition), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0006911](http://purl.obolibrary.org/obo/GO_0006911) (phagocytosis, engulfment), [GO:0050871](http://purl.obolibrary.org/obo/GO_0050871) (positive regulation of B cell activation), [GO:0051289](http://purl.obolibrary.org/obo/GO_0051289) (protein homotetramerization), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0006958](http://purl.obolibrary.org/obo/GO_0006958) (complement activation, classical pathway), [GO:0055002](http://purl.obolibrary.org/obo/GO_0055002) (striated muscle cell development), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0034702](http://purl.obolibrary.org/obo/GO_0034702) (ion channel complex), [GO:0034987](http://purl.obolibrary.org/obo/GO_0034987) (immunoglobulin receptor binding), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:0070888](http://purl.obolibrary.org/obo/GO_0070888) (E-box binding), [GO:0030183](http://purl.obolibrary.org/obo/GO_0030183) (B cell differentiation), [GO:0051260](http://purl.obolibrary.org/obo/GO_0051260) (protein homooligomerization), [GO:0002250](http://purl.obolibrary.org/obo/GO_0002250) (adaptive immune response), [GO:0042100](http://purl.obolibrary.org/obo/GO_0042100) (B cell proliferation), [GO:0043551](http://purl.obolibrary.org/obo/GO_0043551) (regulation of phosphatidylinositol 3-kinase activity), [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity), [GO:0042742](http://purl.obolibrary.org/obo/GO_0042742) (defense response to bacterium), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0019815](http://purl.obolibrary.org/obo/GO_0019815) (B cell receptor complex), [GO:0008286](http://purl.obolibrary.org/obo/GO_0008286) (insulin receptor signaling pathway), [GO:0009897](http://purl.obolibrary.org/obo/GO_0009897) (external side of plasma membrane), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0045666](http://purl.obolibrary.org/obo/GO_0045666) (positive regulation of neuron differentiation), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0005771](http://purl.obolibrary.org/obo/GO_0005771) (multivesicular body), [GO:0042113](http://purl.obolibrary.org/obo/GO_0042113) (B cell activation), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0003823](http://purl.obolibrary.org/obo/GO_0003823) (antigen binding), [GO:0072562](http://purl.obolibrary.org/obo/GO_0072562) (blood microparticle), [GO:0050853](http://purl.obolibrary.org/obo/GO_0050853) (B cell receptor signaling pathway), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0035014](http://purl.obolibrary.org/obo/GO_0035014) (phosphatidylinositol 3-kinase regulator activity), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:0005068](http://purl.obolibrary.org/obo/GO_0005068) (transmembrane receptor protein tyrosine kinase adaptor activity), [GO:0005225](http://purl.obolibrary.org/obo/GO_0005225) (volume-sensitive anion channel activity), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0004888](http://purl.obolibrary.org/obo/GO_0004888) (transmembrane signaling receptor activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0042571](http://purl.obolibrary.org/obo/GO_0042571) (immunoglobulin complex, circulating), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0032496](http://purl.obolibrary.org/obo/GO_0032496) (response to lipopolysaccharide), [GO:0016303](http://purl.obolibrary.org/obo/GO_0016303) (1-phosphatidylinositol-3-kinase activity), 

**Class expressions from DL-Learner:**

- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 53.57%
- [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus) 53.57%
- Thing 52.39%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 38.93%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 38.93%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 38.93%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 38.93%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 38.93%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 38.93%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 38.93%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 38.93%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 38.93%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001041](http://purl.obolibrary.org/obo/GO_2001041) (null)) 38.93%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2000976](http://purl.obolibrary.org/obo/GO_2000976) (obsolete regulation of transcription from RNA polymerase II promoter involved in detection of glucose)) 38.93%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2000745](http://purl.obolibrary.org/obo/GO_2000745) (obsolete positive regulation of transcription from RNA polymerase III promoter involved in smooth muscle cell differentiation)) 38.93%


